- Home
- TALKW vs SNN Comparison
TALKW vs SNN Comparison
Compare TALKW & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALKW
- SNN
- Stock Information
- Founded
- TALKW N/A
- SNN 1856
- Country
- TALKW United States
- SNN United Kingdom
- Employees
- TALKW 472
- SNN N/A
- Industry
- TALKW Medical/Nursing Services
- SNN Industrial Specialties
- Sector
- TALKW Health Care
- SNN Health Care
- Exchange
- TALKW Nasdaq
- SNN Nasdaq
- Market Cap
- TALKW N/A
- SNN 12.4B
- IPO Year
- TALKW 2020
- SNN 1999
- Fundamental
- Price
- TALKW $0.17
- SNN $29.44
- Analyst Decision
- TALKW
- SNN Strong Buy
- Analyst Count
- TALKW 0
- SNN 1
- Target Price
- TALKW N/A
- SNN N/A
- AVG Volume (30 Days)
- TALKW N/A
- SNN 674.7K
- Earning Date
- TALKW N/A
- SNN 08-01-2024
- Dividend Yield
- TALKW N/A
- SNN 2.55%
- EPS Growth
- TALKW N/A
- SNN 39.77
- EPS
- TALKW N/A
- SNN 0.35
- Revenue
- TALKW N/A
- SNN $5,642,000,000.00
- Revenue This Year
- TALKW N/A
- SNN $6.92
- Revenue Next Year
- TALKW N/A
- SNN $5.43
- P/E Ratio
- TALKW N/A
- SNN $41.81
- Revenue Growth
- TALKW N/A
- SNN 5.48
- 52 Week Low
- TALKW N/A
- SNN $21.53
- 52 Week High
- TALKW N/A
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- TALKW N/A
- SNN 46.87
- Support Level
- TALKW N/A
- SNN $28.26
- Resistance Level
- TALKW N/A
- SNN $29.64
- Average True Range (ATR)
- TALKW 0.00
- SNN 0.36
- MACD
- TALKW 0.00
- SNN 0.05
- Stochastic Oscillator
- TALKW 0.00
- SNN 58.65
About TALKW Talkspace Inc. Warrant
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue primarily stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.